Health4 years ago
Medivir and SciLife Lab Launch Joint Research on Potential SARS CoV-2 Inhibitors |
Stockholm, July 6, 2020 / PRNewswire /- Medivir ab (Nasdaq Stockholm: MVIR) today announced that it has participated in a collaborative study with SciLifeLab’s drug development...
Recent Comments